The present study was aimed to investigate optimum pH conditions for polyelectrolyte complexation between gellan gum (GG) and cationic guar gum (CGG). The pKa of both the polymers was determined using potentiometric titrations. The complex formation was investigated at three pH values (based upon the pKa interval of two polymers) and at different mixing ratios (ranging from 10:90 to 90:10). Zeta potential and turbidity studies elucidated the optimum pH and mixing ratio at which maximum interaction takes place between the polymers. The studies revealed neutral zeta potential, highest turbidity, and low transmittance at mixing ratio 30:70 and 40:60 (GG:CGG; pH 5.5), indicating maximum complex formation at these ratios. The percentage yield and viscosity studies of supernatant also revealed maximum interaction at these mixing ratios of polymers. The polyelectrolyte complexes (PECs) were characterized by Fourier transform infrared spectroscopy (FTIR), differential scanning calorimetry (DSC), scanning electron microscopy (SEM), and for their swelling behavior in pH progression medium. The FTIR spectra confirmed formation of bonds between COO¯and -N + (CH 3 ) 3 of GG and CGG, respectively. DSC studies revealed the stability, affinity, and spontaneous nature of complexation between these polymers. The morphological changes detected through SEM studies in GG-CGG PECs exposed to different pH buffers also found to exhibit pH-dependent swelling. The FTIR spectra, DSC, SEM, and swelling studies of PECs treated with buffer pH 1.2 followed by buffer pH 7.4 suggested that PECs comprising 40:60 ratio of GG:CGG, prepared at pH 5.5, could be used to formulate a pH-sensitive drug delivery system.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.